Ngm Biopharmaceuticals Inc
Annual report (10-K)
Latest 10-K/A filed Apr 4, 2024. Sentiment + YoY language diff vs prior year. Read sections →
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Ngm Biopharmaceuticals Inc
| Name | Roles | Filings |
|---|---|---|
| Column Group III-A, LP | 10% Owner | 18 |
| Column Group II Gp, LP | 10% Owner | 18 |
| Column Group IV Gp, LP | 10% Owner | 18 |
| Column Group IV, LP | 10% Owner | 18 |
| Column Group IV-A, LP | 10% Owner | 18 |
All filings
103 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|